Dolphin Medical Services faces a major governance shift following the simultaneous resignation of its MD and CEO, G V Mohan Prasad, alongside two board directors. The sudden departure of top leadership raises questions about operational...
Rekvina Laboratories Ltd has announced the resignation of its Managing Director, Amit Mukesh Shah, effective September 11, 2026. The company cited personal reasons and commitments as the driver behind his departure. Investors are advised...
Aspira Pathlab & Diagnostics Ltd has announced plans to raise up to Rs 65 crore via a rights issue. The company’s board has formed a committee to finalize the pricing, entitlement ratio, and record date. This move signals a capital expan...
Roshan Dealmark Private Limited, a promoter group entity, has sold 18 lakh equity shares of Tavexia Lifecare Ltd through an on-market trade. This transaction reduces the promoter group's total stake in the company from 5.66% to 5.19%.
Lords Mark Industries has announced a strategic shift to prioritize its MedTech business, with plans to rebrand as 'Lords Med' and potentially spin off its renewable energy division. The company projects FY27 revenue at Rs 1,550 crore an...
Molbio Diagnostics announced a robust Q1 FY27 performance with Rs 408 crore in revenue and a 25% EBITDA margin. Driven by its Truenat platform, the company saw 62.4 lakh test kits sold, which now account for 75% of total revenue. With a...
Dr. Reddy's Laboratories reported that its Mexico-based API manufacturing facility, Industrias Químicas Falcón de México, has received two observations from the USFDA following a records assessment. The company stated it will respond wit...
Strides Pharma Science Limited has disclosed that its Alathur, Chennai, formulations facility received a USFDA Form 483 with three observations following a routine cGMP inspection. The company stated it is preparing a response and remedi...
Sun Pharmaceutical Industries announced a settlement agreement in the ongoing 'Generic Pharmaceuticals Pricing Antitrust Litigation' in the U.S. District Court. The deal covers its subsidiaries, including Taro Pharmaceuticals, and provid...
Vijaya Diagnostic Centre Ltd has announced the acquisition of the diagnostic business of Arya Wellness Centre in Guwahati for Rs 46.20 crore. Executed via a slump sale, this strategic move marks the company’s entry into Assam to strength...
Jubilant Pharmova Limited has received a 'Voluntary Action Indicated' (VAI) classification from the USFDA for its Spokane, Washington manufacturing facility. This follows an inspection conducted in June 2026. The classification confirms...
Oxford Industries Ltd has officially approved a major pivot into the healthcare and pharmaceutical sectors following its 45th AGM. Shareholders cleared resolutions to expand the company’s business objects to include hospital management,...
Granules India promoter Dr. Krishna Prasad Chigurupati has sold 1.72 crore equity shares via block and open market deals. The sale, attracting global investors like Capital Group and ChrysCapital, is aimed at funding growth initiatives a...
Aurobindo Pharma’s subsidiary, Apitoria Pharma, has successfully passed a US FDA inspection at its Unit-IV API facility in Andhra Pradesh with zero observations. This clean audit outcome removes potential regulatory hurdles for the compa...
Shalby Limited’s 22nd Annual General Meeting saw shareholders overwhelmingly approve financial statements and auditor remuneration. However, the company faced a major governance setback as resolutions to appoint Mr. Shanay Vikram Shah as...